{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:17:09Z","timestamp":1790813829953,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ymgme.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T11:38:23Z","timestamp":1551872303000},"page":"213-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)"],"prefix":"10.1016","volume":"128","author":[{"given":"Herbert L.","family":"Bonkovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Rudnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ymgme.2019.03.002_bb0005","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"NEJM"},{"issue":"1","key":"10.1016\/j.ymgme.2019.03.002_bb0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/j.2040-4603.2013.tb00488.x","article-title":"Porphyrin and heme metabolism and the porphyrias","volume":"3","author":"Bonkovsky","year":"2013","journal-title":"Compr. Physiol."},{"issue":"9718","key":"10.1016\/j.ymgme.2019.03.002_bb0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2019.03.002_bb0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00365510902935979","article-title":"Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study","volume":"65","author":"Bylesj\u00f6","year":"2009","journal-title":"Scan. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ymgme.2019.03.002_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2796.1997.00189.x","article-title":"Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France","volume":"242","author":"Nordmann","year":"1997","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2019.03.002_bb0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.03.002_bb0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/humu.23067","article-title":"Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease","volume":"37","author":"Chen","year":"2016","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ymgme.2019.03.002_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1471-4159.2000.0750321.x","article-title":"Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus","volume":"75","author":"Novotny","year":"2000","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ymgme.2019.03.002_bb0045","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1471-4159.2007.04905.x","article-title":"Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity","volume":"103","author":"Hu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2019.03.002_bb0050","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.2016080918","article-title":"A variant of peptide transporter 2 predicts the severity of porphyria-associated kidney disease","volume":"28","author":"Tchernitchko","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Nov 30","key":"10.1016\/j.ymgme.2019.03.002_bb0055","article-title":"Recent advances on porphyria genetics: inheritance, penetrance & molecular heterogeneity, including new modifying\/causative genes","author":"Yasuda","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.03.002_bb0060","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1056\/NEJMcpc0803190","article-title":"Case 20-2008. A 57-year-old woman with abdominal pain and weakness after gastric bypass surgery. Case records of the Massachusetts General Hospital","volume":"358","author":"Bonkovsky","year":"2008","journal-title":"New Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ymgme.2019.03.002_bb0065","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2019.03.002_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197001000-00001","article-title":"Acute intermittent porphyria","volume":"49","author":"Stein","year":"1970","journal-title":"Medicine [Baltimore]"},{"issue":"110","key":"10.1016\/j.ymgme.2019.03.002_bb0075","first-page":"183","article-title":"Acute intermittent porphyria. A study of 50 cases","volume":"28","author":"Goldberg","year":"1959","journal-title":"Q. J. Med."},{"key":"10.1016\/j.ymgme.2019.03.002_bb0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-2008-1040701","article-title":"The neurological manifestations of acute porphyria","volume":"2","author":"Bonkowsky","year":"1982","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2019.03.002_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjmed.2014.10.026","article-title":"Role of delta-aminolevulinic acid in the symptoms of acute porphyria","volume":"128","author":"Bissell","year":"2015","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2019.03.002_bb0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1460-9592.2005.01451.x","article-title":"Anesthesia in a child with homozygous porphobilinogen deaminase deficiency: a severe form of acute intermittent porphyria","volume":"15","author":"Sheppard","year":"2005","journal-title":"Pediatr. Anaesth."},{"issue":"11","key":"10.1016\/j.ymgme.2019.03.002_bb0095","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.61.11.1764","article-title":"Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias","volume":"61","author":"Solis","year":"2004","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.03.002_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00207051","article-title":"Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase gene","volume":"89","author":"Llewellyn","year":"1992","journal-title":"Hum. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2019.03.002_bb0105","first-page":"1050","article-title":"Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools","volume":"86","author":"Bonkovsky","year":"1991","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ymgme.2019.03.002_bb0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/0003-4819-144-7-200604040-00023","article-title":"Reconstitution of hematin for intravenous infusion","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.ymgme.2019.03.002_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1212\/WNL.49.1.97","article-title":"Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells--potential implications for patients with acute porphyria","volume":"49","author":"Hahn","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2019.03.002_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197101072840104","article-title":"Blood volume and bilirubin production in acute intermittent porphyria","volume":"284","author":"Bloomer","year":"1971","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2019.03.002_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0920-9964(93)90019-F","article-title":"Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia","volume":"8","author":"Sanders","year":"1993","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.ymgme.2019.03.002_bb0130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1192\/bjp.bp.114.157073","article-title":"Acute intermittent porphyria: comorbidity and shared familial risks with schizophrenia and bipolar disorder in Sweden","volume":"207","author":"Cederlof","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2019.03.002_bb0135","first-page":"723A","article-title":"Explore: a prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks","volume":"68","author":"Bonkovsky","year":"2018","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.ymgme.2019.03.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001023","article-title":"Anthropometric and quality-of-life parameters in acute intermittent porphyria patients","volume":"94","author":"Jim\u00e9nez-Monreal","year":"2015","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.ymgme.2019.03.002_bb0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2016.08.006","article-title":"Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: a qualitative study","volume":"119","author":"Naik","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2019.03.002_bb0150","first-page":"50A","article-title":"Phase 1-2 and open label extension studies of Givosiran, an investigational RNAi therapeutic, in patients with acute intermittent porphyria","volume":"68","author":"Anderson","year":"2018","journal-title":"Hepatology"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219300848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219300848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:23:53Z","timestamp":1761089033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219300848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1096719219300848"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.03.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}